In a warehouse to the northeast of Cambridge are shelves upon shelves of trays teeming with maggots, munching their way through a meal of rotting fruit and vegetables. This may sound stomach-churning, but these insects could become the sustainable food of the future – at least for fish and animals – helping reduce the reliance on resource intensive proteins such as fishmeal and soy, while also mitigating the use of antibiotics in the food chain, one of the causes of the increase in drug-resistant bacteria.
The Prince of Wales Global Sustainability Fellowship Programme represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals.
Entries are now open for the Unilever Young Entrepreneurs Awards, supporting and celebrating inspirational young people from all over the world who have initiatives, products or services that tackle the planet’s biggest sustainability challenges.
The University of Cambridge has signed an agreement with one of China’s largest universities to encourage innovation and entrepreneurship in one of China’s fastest-growing high-tech clusters.
The UK’s fastest academic supercomputer, based at the University of Cambridge, will be made available to artificial intelligence (AI) technology companies from across the UK, in support of the government’s industrial strategy.
Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic resistance presents a grave threat. Now, a team of researchers from across Cambridge, in a major new centre supported by the Cystic Fibrosis Trust, hopes to turn fortunes around.
Five leading universities, including the University of Cambridge, have formed a partnership to develop and commercialise agritech research, in order to improve sustainability, increase productivity and contribute to global food security.
Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has been licensed to Cambridge spin-out company TeraView, who are developing it for use in the pharmaceutical industry in order to make medicines that are more easily released in the body.
Fairness, trust and transparency are qualities we usually associate with organisations or individuals. Today, these attributes might also apply to algorithms. As machine learning systems become more complex and pervasive, Cambridge researchers believe it’s time for new thinking about new technology.
What makes a city as small as Cambridge a hotbed for AI and machine learning start-ups? A critical mass of clever people obviously helps. But there’s more to Cambridge’s success than that.